Suppression of lymphocyte transformation by salicylates.
D000818:Animals; D001170:Arthritis, Infectious / Q000188:drug therapy; D001241:Aspirin / Q000494:pharmacology; D007553:Isotope Labeling; D008213:Lymphocyte Activation / Q000187:drug effects*; D009175:Mycoplasma Infections / Q000188:drug therapy; D051381:Rats; D012459:Salicylates / Q000494:pharmacology*; D012980:Sodium Salicylate / Q000494:pharmacology; D013601:T-Lymphocytes / Q000187:drug effects; D013936:Thymidine
D012459:Salicylates; D001241:Aspirin; D013936:Thymidine; D012980:Sodium Salicylate